Personalis, Inc. (PSNL) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 69.67M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $69.67M | (m) | (m) |
| 2026-03-31 | (m) | $64.52M | (m) | (m) |
| 2025-12-31 | (m) | $69.65M | (m) | (m) |
| 2025-09-30 | (m) | $69.10M | (m) | (m) |
| 2025-06-30 | (m) | $80.32M | (m) | (m) |
| 2025-03-31 | (m) | $85.69M | (m) | (m) |
| 2024-12-31 | (m) | $84.61M | (m) | (m) |
| 2024-09-30 | (m) | $87.49M | (m) | (m) |
| 2024-06-30 | (m) | $80.03M | (m) | (m) |
| 2024-03-31 | (m) | $74.15M | (m) | (m) |
| 2023-12-31 | (m) | $73.48M | (m) | (m) |
| 2023-09-30 | (m) | $70.53M | (m) | (m) |
| 2023-06-30 | (m) | $67.14M | (m) | (m) |
| 2023-03-31 | (m) | $68.68M | (m) | (m) |
| 2022-12-31 | (m) | $65.05M | (m) | (m) |
| 2022-09-30 | (m) | $69.01M | (m) | (m) |
| 2022-06-30 | (m) | $76.41M | (m) | (m) |
| 2022-03-31 | (m) | $79.84M | (m) | (m) |
| 2021-12-31 | (m) | $85.49M | (m) | (m) |
| 2021-09-30 | (m) | $84.99M | (m) | (m) |
| 2021-06-30 | (m) | $82.54M | (m) | (m) |
| 2021-03-31 | (m) | $80.37M | (m) | (m) |
| 2020-12-31 | (m) | $78.65M | (m) | (m) |
| 2020-09-30 | (m) | $76.63M | (m) | (m) |
| 2020-06-30 | (m) | $73.96M | (m) | (m) |
| 2020-03-31 | (m) | $70.29M | (m) | (m) |
| 2019-12-31 | $22.08M | $65.21M | (m) | 33.86% |
| 2019-09-30 | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) |
| 2019-03-31 | $15.69M | $47.69M | (m) | 32.90% |
| 2018-12-31 | $11.80M | $37.77M | (m) | 31.25% |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $9.39M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |